Project Details
Description
A Phase IIB Randomized, Placebo-Controlled Trial of Pioglitazone for Oral Pre-Malignant Lesions: An Inter- Consortium Collaborative Study
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/10 → 9/15/14 |
Funding
- UNIVERSITY OF WISCONSIN-MADISON
- NIH NATIONAL CANCER INSTITUTE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.